The contribution of PET/CT to improved patient management.
With the introduction of both SPET/CT and PET/CT, multimodality imaging has truly entered routine clinical practice. Multiple slice spiral CT scanners have been incorporated with multiple detector gamma cameras or PET systems, such that the benefit of these modalities can be achieved in one patient sitting. The subject of this manuscript is PET/CT and its impact on patient management. Applications of PET/CT span the whole field of medical and surgical oncology since very few cancers do not take up the labelled glucose tracer, (18)F-FDG. Given the contrast achieved, high-quality data can be obtained with FDG PET/CT. This technology has now spread worldwide and has been the subject of intense interest, as witnessed by the vast body of published evidence. In this short overview, only a brief discussion of the main clinical applications is possible. Novel applications of PET/CT outside the field of oncology are expected in the near future.
Ell
P J
PJ
Institute of Nuclear Medicine, UCL, London, UK.
D001859:Bone Neoplasms / Q000000981:diagnostic imaging / Q000556:secondary; D019788:Fluorodeoxyglucose F18; D006801:Humans; D009367:Neoplasm Staging / Q000379:methods; D009369:Neoplasms / Q000000981:diagnostic imaging*; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals; D011880:Radiotherapy Planning, Computer-Assisted
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18